Researchers have identified specific anti-bodies that can have a neutralizing effect on the virus responsible for tick-borne encephalitis. Preliminary response in using the anti-bodies in mice has proven affected in preventing TBE. It is hoped a vaccine candidate for TBE can be developed for humans.
According to a PNAS study, the RNAs of tick borne encephalitis virus (TBEV) are transported from the cell body to dendrites. The viral RNAs then reproduce the viruses within the dendrites, disturbing neural activity.